/Investor DB

R42 Group

Family office

San Francisco · Pre-Seed–Seed · 13 people tracked

Also known as R42

Find your way into R42 Group

Each arrow is one introduction. Sign up to fill in the first one.

365 people can intro you to Zixuan

Ask Ronjon Nag to introduce you to Zixuan An

You →Ronjon · together at R42 Group →Zixuan

298 people can intro you to Anastasiya

Ask Jamie Chen to introduce you to Anastasiya Giarletta

You →Jamie · together at Agemica →Anastasiya

3 people can intro you to Ronjon

Ask Sam Okafor to introduce you to Ronjon Nag

You →Sam · together at R42 Group →Ronjon

Sign up to find every way you can get introduced to R42 Group

  • Your email: who you already know at R42 Group, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the R42 Group team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

R42 focuses on artificial intelligence and science, drawing on a team of scientific advisors and the experience of founder Dr. Ronjon Nag. The firm operates a dual strategy: it invests directly in early-stage companies, leading and backing them from the earliest stages — even when a startup is only an idea without a team — and it invests as a limited partner in funds that share its values, sometimes co-investing alongside those funds. R42 has backed roughly 50 companies, providing founders with hands-on guidance, resources, and access to expert advisors to help accelerate their growth.

Source: firm website, verified Aug 16, 2026.

Stage
Pre-Seed–Seed
HQ
San Francisco
Leads rounds
Leads
Instruments
Equity
Founded
2020
Last 12 months
2 investments
Tracked investments
10

Team · 13 people

from the firm's website & public directories
Anne Friedlander· Adjunct Professor, Human Biology, Stanford University

Adjunct Professor in Human Biology at Stanford University and an advisor to the firm.

Eric Saund· Cognitive Science Researcher, AI/ML Consultant

Researcher in cognitive science and a consultant in AI and machine learning.

Frank Sortino· Director, Pension Research Institute

Director at the Pension Research Institute and creator of the Sortino Ratio.

Michael Snyder· Stanford Professor, Chair of Genetics Department

Stanford Ascherman Professor and Chair of the Genetics Department.

What they invest in

from 9 of 10 portfolio companies

Biotech ×7Deep Tech ×5Healthtech ×5AI & Machine Learning ×3Digital Health ×2Hardware ×2Longevity ×2Medical Devices ×2

HQs:United Kingdom×6United States×3

Investments · 10 tracked

founders shown can be your intro path

By year:2026 · 12025 · 12024 · 22022 · 42021 · 19 dated

xWattsxwatts.coinFeb 2026✓ verified

xWatts is an intelligent energy management platform that connects to building energy systems, models facilities in real time, and automatically optimizes assets like HVAC, solar, and CHP engines to reduce energy costs and emissions in large, complex estates and industrial facilities.

CleantechClimate TechEnergyEnterprise SoftwarePropTech

Yigit Akar(Co-founder & CEO)inAlex Allen(Co-founder & CPO)Alexander A.(Founder)in

Co-investorsAntlerCambridge Angels groupParkwalk AdvisorsPlug and Play Ventures

Abselionabselion.comin𝕏Dec 2024

Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.

BiotechDeep TechHardwareMedical DevicesCambridge, GB

Dr Ruizhi Wang(CEO)

Co-investorsCambridge Angels groupM Ventures

Bounce Imagingbounceimaging.comin𝕏May 2022 · $4.2M

Bounce Imaging manufactures tactical 360-degree camera systems and robotics for first responders, law enforcement, and military personnel to safely assess confined spaces.

Defense TechHardwareRoboticsBuffalo, US

Francisco Aguilar(Executive Officer, Director)inRonjon Nag(Director)inJames Smist(Director)Sietse Dijkstra(Executive Officer)inMark Fargason(Executive Officer)inMikhail Fridberg(Executive Officer)in

Co-investorsIn-Q-TelBantam GroupBerkeley Angel NetworkBroad Street AngelsBrown and White VenturesDC Investment Partners+7 more

Cordance Medicalcordancemedical.comin𝕏Nov 2025

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US

Ryan Dittamore(CEO)in

Co-investorsAngel Physicians FundBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Shanda GroupSmartGateVC+1 more

Exogeneexogene.co.ukApr 2022

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in

Co-investorsBeresford VenturesEntrepreneur FirstJude GomilaSelvedge VentureUnruly CapitalCambridge Angels group+1 more

Fountain Therapeuticsfountainml.cominNov 2021

Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates.

BiotechHealthtechLongevitySan Francisco, US

Thomas Rando(Co-founder)Joseph Rodgers(Co-founder)inTom Cheung(Co-founder)inTsang(Chief Business Officer)

Co-investorsAlexandriaKhosla VenturesNan Fung Life Sciences

Healxhealx.aiin𝕏Aug 2024 · $47M

Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence.

AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB

Tim Guilliams(Founder)inDr David Brown(Co-Founder and Board member)inDavid J. Brown(Founder)in

Co-investorsAmadeus Capital PartnersAurum Venture PartnersBalderton CapitalCambridge Angels groupDaniel GutenbergGlobal Brain+4 more

Seniscasenisca.com

SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease.

BiotechDeep TechLongevity

Lorna Harries(Founder)in

Co-investorsAPEX VenturesLifespan Vision Ventures

Spireaspirea.co.ukinJun 2022 · $3M

Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases.

BiotechDeep TechHealthtech

Myriam Ouberai(Founder)inBo Rode Hansen(Executive Director)in

Co-investorsCambridge Angels groupStart CodonACF InvestorsO2h Ventures

Stampstamp.eeMay 2022

This is a domain sales landing page offering the premium .ee domain "stamp.ee" for purchase, operated by Computernik OÜ.

Co-investorsNielsen InnovateSecond Century Ventures

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has R42 Group made?
R42 Group has 10 tracked investments, including 3 dated in the last 24 months.
What stage does R42 Group invest at?
R42 Group invests at the Pre-Seed, Seed stages.
What sectors does R42 Group focus on?
R42 Group focuses on AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Longevity, SaaS.
Where is R42 Group located?
R42 Group is headquartered in San Francisco.
Does R42 Group lead rounds?
Yes, R42 Group leads investment rounds.

Media · Podcasts & interviews

featuring the team

Can We Hack the Aging Code? Dr. Ronjon Nag on Using AI to Cure Cancer & Extend Life- R42 Group

Ones Changing The World - 1CW · Ronjon Nag

Images

R42 Group photo

Similar investors

Featured in lists